SaeedaKirmaniMD

Oncology • San Diego, CA

Hematologic Oncology

Professor, Medicine, UCSD School of Medicine

Join to view full profile

Dr. Kirmani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kirmani's full profile

Already have an account?

Office
3350 La Jolla Village Dr # 111e
San Diego, CA 92161
Phone+1 858-552-8585

Fax+1 858-552-7485
Is this information wrong?

Education & Training

Letterman Army Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1982
University of MarylandResidency, Internal Medicine, 1975 - 1979
King Edward Medical UniversityClass of 1974

Certifications & Licensure

CA State Medical License 1979 - 2024
MD State Medical License 1978 - 1996
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
Completed
Phase 3
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2008 Feb 29
Active, not recruiting
Phase 3
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Start of enrollment: 2011 Jan 01
Completed
Phase 3

Publications & Presentations

PubMed

10 citations
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel
M M de las Alas, R D Christen, Dennis P. Gately, D E Weiner, Benbatoul K, Salman Kirmani, Horacio B. D'Agostino, Steven C. Plaxe, D. Darrah, Edward F. McClay, Stefan A...> ;Cancer Chemotherapy and Pharmacology. 2000 Jan 1
16 citations
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel
Stefan Aebi, T. W. Schnider, Gerrit Los, Dennis D. Heath, D. Darrah, Saeeda Kirmani, Edward F. McClay, Horacio B. D'Agostino, Steven C. Plaxe, D Fink, M M de las Alas,...> ;Cancer Chemotherapy and Pharmacology. 1999 Jan 1
14 citations
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma.
Edward F. McClay, Patricia D. Braly, Saeeda Kirmani, Steven C. Plaxe, Sinil Kim, Mary Eileen McClay, Linda Wilgus, Stephen B. Howell> ;American Journal of Clinical Oncology. 1995 Feb 1
16 citations
Phase I Trial of Cisplatin in Combination with Glutathione
Steven C. Plaxe, James L. Freddo, Sinil Kim, Saeeda Kirmani, Edward F. McClay, R D Christen, Patricia S. Braly, Stephen H. Howell> ;Gynecologic Oncology. 1994 Oct 1
71 citations
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.
Saeeda Kirmani, Patricia S. Braly, Edward F. McClay, Sidney L. Saltztein, Steven C. Plaxe, Sinil Kim, Charles Cates, Stephen B. Howell> ;Gynecologic Oncology. 1994 Sep 1
3 citations
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies.
Edward F. McClay, Patricia D. Braly, Saeeda Kirmani, Steven C. Plaxe, Mary Eileen McClay, Linda Wilgus, Sinil Kim, Stephen B. Howell> ;Cancer. 1994 Jul 15
30 citations
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin.
R D Christen, Edward F. McClay, Steven C. Plaxe, S S Yen, Sinil Kim, Saeeda Kirmani, Linda Wilgus, Dennis D. Heath, D R Shalinsky, James L. Freddo> ;Journal of Clinical Oncology. 1993 Dec 1
4 citations
Phase I and Pharmacokinetic Study of Intraperitoneal Ormaplatin
Steven C. Plaxe, Patricia S. Braly, James L. Freddo, Edward F. McClay, R D Christen, Saeeda Kirmani, Sinil Kim, Dennis D. Heath, Stephen B. Howell> ;Gynecologic Oncology. 1993 Oct 1
3 citations
High-Dose Biweekly Intraperitoneal Cisplatin: An Effective Way to Increase Cisplatin Dose Intensity
Andrea Bonetti, Stephen B. Howell, Edward F. McClay, Saeeda Kirmani, Rakesh Goel, S.C. Plaxe, Patricia S. Braly, Sinil Kim> ;Gynecologic Oncology. 1993 Jun 1
22 citations
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
Seiji Isonishi, Saeeda Kirmani, Sinil Kim, Steven C. Plaxe, Patricia S. Braly, Edward F. McClay, Stephen B. Howell> ;Journal of the National Cancer Institute. 1991 May 1
29 citations
Acute renal failure associated with the use of intraperitoneal carboplatin: A report of two cases and review of the literature
Brian R. McDonald, Saeeda Kirmani, Martha Vasquez, Ravindra L. Mehta> ;The American Journal of Medicine. 1991 Jan 1
5 citations
A phase I clinical trial of intraperitoneal thiotepa for refractory ovarian cancer
Salman Kirmani, L McVey, David Loo, Stephen B. Howell> ;Gynecologic Oncology. 1990 Mar 1
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
Saeeda Kirmani, Solomon Zimm, Cleary S, Jeanne Mowry, Stephen B. Howell> ;Cancer Chemotherapy and Pharmacology. 1990 Jan 1
5 citations
Post‐transfusion purpura and isoimmune neonatal thrombocytopenia in the same family
Everardo Cobos, David R. Gandara, Larry J. Geier, Saeeda Kirmani> ;American Journal of Hematology. 1989 Nov 1
74 citations
Effect of Sodium Thiosulfate on the Pharmacokinetics and Toxicity of Cisplatin
Rakesh Goel, Stephen M. Cleary, Carol Horton, Saeeda Kirmani, Ian Abramson, Colleen Kelly, Stephen B. Howell> ;Journal of the National Cancer Institute. 1989 Oct 18
19 citations
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
Rakesh Goel, Stephen Cleary, Carol Horton, Frank M. Balis, Solomon Zimm, Saeeda Kirmani, Stephen B. Howell> ;Journal of Clinical Oncology. 1989 Feb 1
Join now to see all